KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 83 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,613 | -60.2% | 16,985 | +14.4% | 0.00% | – |
| Q4 2022 | $104,516 | -23.7% | 14,846 | -6.4% | 0.00% | – |
| Q3 2022 | $137,000 | -56.8% | 15,869 | -58.5% | 0.00% | -100.0% |
| Q2 2022 | $317,000 | +27.8% | 38,271 | +156.2% | 0.00% | – |
| Q1 2022 | $248,000 | +44.2% | 14,939 | +45.6% | 0.00% | – |
| Q4 2021 | $172,000 | +33.3% | 10,259 | -58.6% | 0.00% | – |
| Q4 2020 | $129,000 | – | 24,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |